R&D AI can help us build a new, more precise, antibiotic pipelin... AI has begun to influence early-stage antibiotic discovery by identifying novel antibacterial compounds that are difficult to uncover traditionally.
News Scientists issue call to arms over antifungal resistance Infectious disease experts from around the world are calling for concerted action to combat a "silent surge" in resistance to antifungal drugs.
News EU invests €30m to fight antimicrobial resistance The EU has pledged €30m in funding for countermeasures to antimicrobial resistance, earmarked for the discovery and development of new antibacterials.
R&D Europe has the tools to fight superbugs. Let’s use them. Data shows countries are off track – increasing the risk of profound health and economic consequences from AMR. Medical technologies can help.
News GSK pumps £45m into antimicrobial resistance projects GSK has revealed the six projects it will fund with the Fleming Initiative on antimicrobial resistance, set up with Imperial College London last year.
News GSK will file oral carbapenem for complicated UTIs this year GSK and Spero's cabapenem tebipenem is the first oral antibiotic in the class to show efficacy in complicated urinary tract infections.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.